Viewing Study NCT05429918


Ignite Creation Date: 2025-12-25 @ 4:34 AM
Ignite Modification Date: 2025-12-26 @ 3:36 AM
Study NCT ID: NCT05429918
Status: UNKNOWN
Last Update Posted: 2022-06-23
First Post: 2021-07-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Ibrutinib Combined With R-CHOP/R-DHAP in Newly Diagnosed Mantle Cell Lymphoma Patients Who Aged ≤65 Years
Sponsor: Peking University Third Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module